المؤلفون: Baker MA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: meghan_baker@harvardpilgrim.org., Jankosky C; FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Yih WK; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Gruber S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Li L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Lipowicz H; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Coronel-Moreno C; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., DeLuccia S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Lin ND; OptumInsight Life Sciences, Boston, MA, USA., McMahill-Walraven CN; Aetna, Blue Bell, PA, USA., Menschik D; FDA Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Selvan MS; Humana Healthcare Research (HHR), USA(7)., Selvam N; HealthCore, Inc., Alexandria, VA, USA., Chen Tilney R; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Zichittella L; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Lee GM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Kawai AT; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.

المصدر: Vaccine [Vaccine] 2020 Feb 24; Vol. 38 (9), pp. 2166-2171. Date of Electronic Publication: 2020 Feb 01.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Seizures, Febrile*/chemically induced , Seizures, Febrile*/epidemiology, Influenza Vaccines/*adverse effects , Pneumococcal Vaccines/*adverse effects, Humans ; Infant ; Sentinel Surveillance ; United States ; Vaccines, Conjugate/adverse effects

المؤلفون: Woo EJ; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States. Electronic address: jane.woo@fda.hhs.gov., Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Cano M; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Jankosky C; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.

المصدر: Vaccine [Vaccine] 2017 Oct 09; Vol. 35 (42), pp. 5618-5621. Date of Electronic Publication: 2017 Sep 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Adverse Drug Reaction Reporting Systems/*statistics & numerical data , Drug-Related Side Effects and Adverse Reactions/*immunology , Influenza Vaccines/*adverse effects , Influenza Vaccines/*immunology , Influenza, Human/*immunology , Product Surveillance, Postmarketing/*statistics & numerical data, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Hypersensitivity, Immediate/chemically induced ; Hypersensitivity, Immediate/immunology ; Male ; Middle Aged ; United States ; United States Food and Drug Administration ; Vaccination/methods ; Young Adult

المؤلفون: Haber P; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States. Electronic address: PHaber@cdc.gov., Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States., Lewis P; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States., Woo EJ; Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, Silver Spring, MD, United States., Jankosky C; Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, Silver Spring, MD, United States., Cano M; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States.

المصدر: Vaccine [Vaccine] 2016 May 11; Vol. 34 (22), pp. 2507-12. Date of Electronic Publication: 2016 Mar 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing*, Influenza Vaccines/*adverse effects , Influenza, Human/*prevention & control, Adolescent ; Anaphylaxis/etiology ; Bayes Theorem ; Child ; Child, Preschool ; Data Mining ; Female ; Fever/etiology ; Guillain-Barre Syndrome/etiology ; Humans ; Infant ; Influenza Vaccines/administration & dosage ; Influenza, Human/virology ; Licensure ; Male ; Seizures/etiology ; United States ; Vaccines, Inactivated/administration & dosage ; Vaccines, Inactivated/adverse effects

المؤلفون: Jankosky C; Division of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Deussing E, Gibson RL, Haverkos HW

المصدر: Virus research [Virus Res] 2012 Feb; Vol. 163 (2), pp. 424-30. Date of Electronic Publication: 2011 Nov 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7492 (Electronic) Linking ISSN: 01681702 NLM ISO Abbreviation: Virus Res Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*etiology , Multiple Sclerosis/*etiology, Chronic Disease ; Enterovirus Infections/complications ; Humans ; Models, Biological ; Vitamin D Deficiency/complications